Conformational regulation of the EGFR kinase core by the juxtamembrane and C‐terminal tail: A molecular dynamics study

The catalytic domain of epidermal growth factor receptor (EGFR) is activated by dimerization, which requires allosteric coupling between distal dimerization and catalytic sites. Although crystal structures of EGFR kinases, solved in various conformational states, have provided important insights into EGFR activation by dimerization, the atomic details of how dimerization signals are dynamically coupled to catalytic regions of the kinase core are not fully understood. In this study, we have performed unrestrained and targeted molecular dynamics simulations on the active and inactive states of EGFR, followed by principal component analysis on the simulated trajectories, to identify correlated motions in the EGFR kinase domain upon dimerization. Our analysis reveals that the conformational changes associated with the catalytic functions of the kinase core are highly correlated with motions in the juxtamembrane (JM) and C‐terminal tail, two flexible structural elements that play an active role in EGFR kinase activation and dimerization. In particular, the opening and closing of the ATP binding lobe relative to the substrate binding lobe is highly correlated with motions in the JM and C‐terminal tail, suggesting that ATP and substrate binding can be coordinated with dimerization through conformational changes in the JM and C‐terminal tail. Our study pinpoints key residues involved in this conformational coupling, and provides new insights into the role of the JM and C‐terminal tail segments in EGFR kinase functions. Proteins 2010. © 2010 Wiley‐Liss, Inc.

[1]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[2]  R. Radhakrishnan,et al.  Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study. , 2009, Biophysical journal.

[3]  J. Schlessinger,et al.  Signaling by Receptor Tyrosine Kinases , 1993 .

[4]  Nicholas M. Glykos,et al.  Software news and updates carma: A molecular dynamics analysis program , 2006, J. Comput. Chem..

[5]  G. M. Walton,et al.  Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. , 1990, The Journal of biological chemistry.

[6]  L. Chin,et al.  Mig-6 controls EGFR trafficking and suppresses gliomagenesis , 2010, Proceedings of the National Academy of Sciences.

[7]  J. Schlessinger Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[8]  Roy S Herbst,et al.  Review of epidermal growth factor receptor biology. , 2004, International journal of radiation oncology, biology, physics.

[9]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[10]  M. Lamers,et al.  Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine. , 1999, Journal of molecular biology.

[11]  Balazs Halmos,et al.  Structure and clinical relevance of the epidermal growth factor receptor in human cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Andrew D. Yates,et al.  Somatic mutations of the protein kinase gene family in human lung cancer. , 2005, Cancer research.

[13]  Kornelia Polyak,et al.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex , 1995, Nature.

[14]  A. Hinnebusch,et al.  Structural Basis for Autoinhibition and Mutational Activation of Eukaryotic Initiation Factor 2α Protein Kinase GCN2*[boxs] , 2005, Journal of Biological Chemistry.

[15]  Heather A. Carlson,et al.  Development of polyphosphate parameters for use with the AMBER force field , 2003, J. Comput. Chem..

[16]  Gennady Verkhivker,et al.  Hierarchical Modeling of Activation Mechanisms in the ABL and EGFR Kinase Domains: Thermodynamic and Mechanistic Catalysts of Kinase Activation by Cancer Mutations , 2009, PLoS Comput. Biol..

[17]  Ron Bose,et al.  Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface , 2007, Nature.

[18]  J. Zheng,et al.  Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.

[19]  Edgar R. Wood,et al.  6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases , 2008, Proceedings of the National Academy of Sciences.

[20]  John Kuriyan,et al.  Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3 , 2009, Proceedings of the National Academy of Sciences.

[21]  Forest M White,et al.  Oncogenic EGFR Signaling Networks in Glioma , 2009, Science Signaling.

[22]  Chao Zhang,et al.  Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. , 2007, Nature chemical biology.

[23]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[24]  Fotini Tzortzatou-Stathopoulou,et al.  Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation , 2009, Proteins.

[25]  Krystal J Alligood,et al.  A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) , 2004, Cancer Research.

[26]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[27]  Matthew Meyerson,et al.  Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. , 2007, Cancer cell.

[28]  John Kuriyan,et al.  An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor , 2006, Cell.

[29]  Ming-Li Xiang,et al.  Detailed conformational dynamics of juxtamembrane region and activation loop in c‐Kit kinase activation process , 2008, Proteins.

[30]  Andrew F Neuwald,et al.  The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module , 2007, Proceedings of the National Academy of Sciences.

[31]  M. Sliwkowski,et al.  An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. , 2003, Molecular cell.

[32]  H. Lane,et al.  ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors , 2005, Nature Reviews Cancer.

[33]  Anna Maria Almerico,et al.  Principal component analysis on molecular descriptors as an alternative point of view in the search of new Hsp90 inhibitors , 2009, Comput. Biol. Chem..

[34]  Sarel J Fleishman,et al.  A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. , 2004, Structure.

[35]  N. Xuong,et al.  A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. , 1997, Structure.

[36]  Ivet Bahar,et al.  Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): insights into functional dynamics , 2009, Bioinform..

[37]  A. Pozzi,et al.  The juxtamembrane region of the EGF receptor functions as an activation domain. , 2009, Molecular cell.

[38]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[39]  M. Meyerson,et al.  The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP , 2008, Proceedings of the National Academy of Sciences.

[40]  John Kuriyan,et al.  Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment , 2009, Cell.

[41]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.